National Research Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Trent Green
- Full Time Employees
- 368
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 1245 Q Street Lincoln NE United States of America 68508
- IPO Date
- May 23, 2013
- CIK
- 0000070487
- Website
- nrchealth.com
- Similar Companies
- Business
- National Research Corporation (NRC) operates as a healthcare insights and analytics company specializing in healthcare experience management solutions designed to enhance patient, employee, physician, and consumer engagement. Its core offerings include multi-channel feedback collection and analysis platforms; patient and family experience measurement; resident and family experience programs for long-term care; employee and physician engagement solutions; healthcare analytics encompassing market and clinical outcomes analysis; health risk assessments; patient outreach initiatives; and integrated healthcare experience management solutions. NRC delivers these services primarily to healthcare providers, hospitals, and long-term care facilities across the United States with a strong emphasis on human-centered conversational listening enhanced by next-generation artificial intelligence technologies. Founded in 1981 and headquartered in Lincoln, Nebraska, NRC has recently focused on transformative growth by integrating advanced AI capabilities into its product suite to deliver more adaptive and personalized healthcare experience management tools. In 2024–2025, the company intensified investments in AI-enhanced healthcare-specific solutions set for market rollout, expanded its sales force, and pursued strategic initiatives to deepen customer engagement and market penetration. NRC also returned $18 million to shareholders through dividends and stock repurchases during the first quarter of 2024, signaling robust financial stewardship. The company's strategic roadmap includes leveraging AI and broadening its healthcare experience platform to better serve evolving client needs in a competitive market. NRC continues to reinforce its position as a leader in healthcare experience analytics by advancing innovative solutions that address regulatory compliance, patient satisfaction, and operational performance improvements. NRC operates exclusively in the healthcare industry with offerings tailored to hospitals, healthcare systems, long-term care providers, and related healthcare organizations across North America. The company maintains a comprehensive portfolio of market insights, consumer assessment programs (including CMS-approved surveys), clinical analytics, and consulting services. Its recent operational enhancements and AI focus position NRC at the forefront of delivering actionable data-driven insights that help healthcare organizations optimize patient outcomes, satisfaction, and loyalty while navigating regulatory and market pressures effectively.
The Governance Institute Announces Blue Ribbon Committee on Health System Governance
The Governance Institute Announces Blue Ribbon Committee on Health System Governance
Is NuScale's NRC Licensing Lead Its Biggest Competitive Advantage?
Advanced Reactors Hit Key Commercialization Milestones
NRC Issues Environmental Assessment with 'Finding of No Significant Impact' for Dow and X-energy's Proposed Advanced Nuclear Project in Texas
Innovotech Inc. Receives Support to Develop Antimicrobial Testing Services and Product Enhancements
Nations Royalty Grants Incentive Stock Options
NRC Health (NRC) Q1 2026 Earnings Call Transcript
NRC Health Announces First Quarter 2026 Results
NRC Authorizes FPL's St. Lucie Nuclear Plant to Operate for Another 20 Years
NANO Nuclear Sees KRONOS MMR™ Well-Aligned with NRC's Evolving Advanced Reactor Frameworks Under Part 53 and Proposed Part 57
NANO Nuclear Sees KRONOS MMR Well-Aligned with NRC's Evolving Advanced Reactor Frameworks Under Part 53 and Proposed Part 57
The Governance Institute Releases Falling Behind Report, Warning Health System Operations Are Advancing Faster than Governance
Questor Technology Secures $1.9 Million from National Research Council Canada to Commercialize 1500kW Heat-to-Power System
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
NRC Health Surges 62% in a Year: Should You Buy the Stock?
Piedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven Growth
National Research (NASDAQ:NRC) Stock Passes Above Two Hundred Day Moving Average – Here’s Why
Volatus Aerospace Receives NRC-IRAP Funding to Support Condor XL Development
NRC Health Announces Board Authorization of $60 Million Share Repurchase Program